Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Glen Gejerman

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 23, 2008
Quality of life of men treated for localized prostate cancer: outcomes at 6 and 12 monthsElise L Lev, Lucille Sanzero Eller, Glen Gejerman, et al.
Nursing Research|April 8, 2006
Prospective study of quality of life of patients receiving treatment for prostate cancerLucille Sanzero Eller, Elise L Lev, Glen Gejerman, et al.
Investigative and Clinical Urology|July 10, 2018
Corrigendum: Incorrect Spelling of Author's Name: US Preventive Services Task Force prostate-specific antigen screening guidelines result in higher Gleason score diagnosesGlen Gejerman, Patrick Ciccone, Martin Goldstein, et al.
Investigative and Clinical Urology|November 11, 2017
US Preventive Services Task Force prostate-specific antigen screening guidelines result in higher Gleason score diagnosesGlen Gejerman, Patrick Ciccone, Martin Goldstein, et al.
World Journal of Urology|October 27, 2006
Exploratory factor analysis: strategies used by patients to promote healthElise L Lev, Lucille Sanzero Eller, John Kolassa, et al.
The Lancet. Oncology|June 1, 2026
Aglatimagene besadenovec (CAN-2409) with radiotherapy for patients with localised prostate cancer: a phase 3, multicentre, randomised, double-blind, placebo-controlled trialTheodore L DeWeese, Andrea Manzanera, John Sylvester, et al.
JAMA Oncology|February 9, 2023
Hyaluronic Acid Spacer for Hypofractionated Prostate Radiation Therapy: A Randomized Clinical TrialNeil F Mariados, Peter F Orio, Zvi Schiffman, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 23, 2008
Quality of life of men treated for localized prostate cancer: outcomes at 6 and 12 monthsElise L Lev, Lucille Sanzero Eller, Glen Gejerman, et al.
Nursing Research|April 8, 2006
Prospective study of quality of life of patients receiving treatment for prostate cancerLucille Sanzero Eller, Elise L Lev, Glen Gejerman, et al.
Investigative and Clinical Urology|July 10, 2018
Corrigendum: Incorrect Spelling of Author's Name: US Preventive Services Task Force prostate-specific antigen screening guidelines result in higher Gleason score diagnosesGlen Gejerman, Patrick Ciccone, Martin Goldstein, et al.
Investigative and Clinical Urology|November 11, 2017
US Preventive Services Task Force prostate-specific antigen screening guidelines result in higher Gleason score diagnosesGlen Gejerman, Patrick Ciccone, Martin Goldstein, et al.
World Journal of Urology|October 27, 2006
Exploratory factor analysis: strategies used by patients to promote healthElise L Lev, Lucille Sanzero Eller, John Kolassa, et al.
The Lancet. Oncology|June 1, 2026
Aglatimagene besadenovec (CAN-2409) with radiotherapy for patients with localised prostate cancer: a phase 3, multicentre, randomised, double-blind, placebo-controlled trialTheodore L DeWeese, Andrea Manzanera, John Sylvester, et al.
JAMA Oncology|February 9, 2023
Hyaluronic Acid Spacer for Hypofractionated Prostate Radiation Therapy: A Randomized Clinical TrialNeil F Mariados, Peter F Orio, Zvi Schiffman, et al.
Pageof 2